A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

The FDA plans to approve selected high-priority drug application submissions in 1 to 2 months rather than 10 to 12.

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

Routine SLNB may be used to predict tumor invasion levels and SLN metastasis in patients with EMPD who do not have enlarged lymph nodes.

A survey of more than 20,000 patients revealed a lack of trust in information about cancer, whether it comes from scientists, ...

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

The efficacy and safety of efinaconazole 10% solution is acceptable among older adults with onychomycosis and comparable to the general population.

The leading causes of readmission among patients who received THA included sepsis (14.6%), nonseptic infections (14.8%), ...

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.

Prademagene zamikeracel, a gene-modified treatment applied surgically, was seen to increase wound healing and pain in RDEB.